KDM2B and Alzheimer disease: Identifying the downstream targets of these pathways would be interesting, especially given that the dysregulation of G9a and GLP in AD mice functioned to enhance methylation, and KDM2B, a demethylase, was downregulated in postmortem brain tissue from patients with AD.